Leerink Partnrs Brokers Decrease Earnings Estimates for UNH

UnitedHealth Group Incorporated (NYSE:UNH) – Equities researchers at Leerink Partnrs reduced their Q2 2025 earnings estimates for UnitedHealth Group in a research report issued on Tuesday, October 15th. Leerink Partnrs analyst W. Mayo now expects that the healthcare conglomerate will post earnings per share of $7.47 for the quarter, down from their prior estimate of $7.61. The consensus estimate for UnitedHealth Group’s current full-year earnings is $27.68 per share. Leerink Partnrs also issued estimates for UnitedHealth Group’s Q3 2025 earnings at $7.51 EPS.

UnitedHealth Group (NYSE:UNH) last announced its quarterly earnings data on Tuesday, October 15th. The healthcare conglomerate reported $7.15 earnings per share (EPS) for the quarter, beating analysts’ consensus estimates of $7.00 by $0.15. The business had revenue of $100.82 billion during the quarter, compared to analysts’ expectations of $99.14 billion. UnitedHealth Group had a return on equity of 26.55% and a net margin of 3.66%. The firm’s quarterly revenue was up 9.2% compared to the same quarter last year. During the same quarter in the previous year, the business earned $6.56 earnings per share.

Several other brokerages also recently commented on UNH. Morgan Stanley cut their target price on UnitedHealth Group from $615.00 to $610.00 and set an “overweight” rating on the stock in a research note on Wednesday. Royal Bank of Canada decreased their target price on UnitedHealth Group from $615.00 to $595.00 and set an “outperform” rating for the company in a research report on Wednesday. HSBC lowered shares of UnitedHealth Group from a “buy” rating to a “hold” rating in a research note on Thursday. Argus raised their target price on shares of UnitedHealth Group from $570.00 to $600.00 and gave the stock a “buy” rating in a report on Wednesday, July 17th. Finally, Truist Financial reissued a “buy” rating and set a $625.00 price target (down from $640.00) on shares of UnitedHealth Group in a report on Wednesday. Two investment analysts have rated the stock with a hold rating, eighteen have assigned a buy rating and two have given a strong buy rating to the stock. According to MarketBeat.com, UnitedHealth Group currently has a consensus rating of “Buy” and a consensus target price of $615.16.

UnitedHealth Group Trading Down 0.9 %

Shares of NYSE UNH opened at $566.00 on Thursday. UnitedHealth Group has a 52-week low of $436.38 and a 52-week high of $608.63. The company has a market cap of $522.66 billion, a PE ratio of 37.53, a P/E/G ratio of 1.69 and a beta of 0.58. The firm’s 50 day moving average price is $584.20 and its 200-day moving average price is $533.07. The company has a debt-to-equity ratio of 0.67, a quick ratio of 0.88 and a current ratio of 0.88.

UnitedHealth Group Dividend Announcement

The business also recently declared a quarterly dividend, which was paid on Tuesday, September 24th. Shareholders of record on Monday, September 16th were issued a $2.10 dividend. The ex-dividend date of this dividend was Monday, September 16th. This represents a $8.40 dividend on an annualized basis and a yield of 1.48%. UnitedHealth Group’s dividend payout ratio is currently 55.70%.

Hedge Funds Weigh In On UnitedHealth Group

Institutional investors have recently added to or reduced their stakes in the company. Beese Fulmer Investment Management Inc. boosted its stake in shares of UnitedHealth Group by 1,262.2% during the 1st quarter. Beese Fulmer Investment Management Inc. now owns 20,623 shares of the healthcare conglomerate’s stock worth $10,202,000 after purchasing an additional 19,109 shares during the period. Marion Wealth Management boosted its holdings in UnitedHealth Group by 1.8% during the 1st quarter. Marion Wealth Management now owns 4,733 shares of the healthcare conglomerate’s stock valued at $2,341,000 after acquiring an additional 82 shares during the period. Atlas Brown Inc. boosted its stake in shares of UnitedHealth Group by 1.4% during the first quarter. Atlas Brown Inc. now owns 1,682 shares of the healthcare conglomerate’s stock valued at $832,000 after purchasing an additional 24 shares during the period. Emprise Bank purchased a new position in shares of UnitedHealth Group during the first quarter worth approximately $1,908,000. Finally, Rise Advisors LLC increased its holdings in UnitedHealth Group by 225.8% during the 1st quarter. Rise Advisors LLC now owns 694 shares of the healthcare conglomerate’s stock worth $344,000 after purchasing an additional 481 shares during the period. Hedge funds and other institutional investors own 87.86% of the company’s stock.

UnitedHealth Group Company Profile

UnitedHealth Group Incorporated operates as a diversified health care company in the United States. The company operates through four segments: UnitedHealthcare, Optum Health, Optum Insight, and Optum Rx. The UnitedHealthcare segment offers consumer-oriented health benefit plans and services for national employers, public sector employers, mid-sized employers, small businesses, and individuals; health care coverage, and health and well-being services to individuals age 50 and older addressing their needs; Medicaid plans, children's health insurance and health care programs; and health and dental benefits, and hospital and clinical services, as well as health care benefits products and services to state programs caring for the economically disadvantaged, medically underserved, and those without the benefit of employer-funded health care coverage.